| Literature DB >> 27893585 |
Lora R Dagi Glass1, Donald P Lawrence, Frederick A Jakobiec, Suzanne K Freitag.
Abstract
This report demonstrates a unique case of conjunctival melanoma harboring a BRAF V600E mutation responsive to systemic therapy with BRAF and MEK inhibitors. While systemic therapy would not be appropriate in patients with local disease alone, it may act therapeutically in cases of higher stage ocular surface and eyelid melanoma.Entities:
Mesh：
Substances：
Year: 2017 PMID： 27893585 DOI： 10.1097/IOP.0000000000000833
Source DB: PubMed Journal: Ophthalmic Plast Reconstr Surg ISSN： 0740-9303 Impact factor: 1.746